Christy Jones

CIK: 0002048467

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (40.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BBNX

Beta Bionics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (10 total)

BBNX
Beta Bionics, Inc.
Sep 22, 2026
Sale(S)
Direct
6.4K shares at avg. $23.00$148K
BBNX
Beta Bionics, Inc.
Jun 24, 2026
Sale(S)
Direct
1.4K shares at avg. $15.00$21K
BBNX
Beta Bionics, Inc.
Jun 4, 2026
Sale(S)
Direct
2.8K shares at avg. $14.00$39K
BBNX
Beta Bionics, Inc.
May 21, 2026
Sale(S)
Direct
2K shares at avg. $9.95$20K
BBNX
Beta Bionics, Inc.
May 21, 2026
Award(A)
Direct
17K shares-
BBNX
Beta Bionics, Inc.
Jan 13, 2026
Award(A)
Direct
4K shares-
BBNX
Beta Bionics, Inc.
Mar 15, 2025
Award(A)
Direct
11.2K shares-
BBNX
Beta Bionics, Inc.
Jan 31, 2025
Award(A)
Director Stock Option (right to buy)
Direct
9.1K shares-
BBNX
Beta Bionics, Inc.
Jan 31, 2025
Award(A)
Director Stock Option (right to buy)
Direct
9.1K shares-
BBNX
Beta Bionics, Inc.
Jan 31, 2025
Award(A)
Director Stock Option (right to buy)
Direct
48.7K shares-

		Type	Shares	Price		Ownership
Sep 22, 2026	BBNX Beta Bionics, Inc.	Sale(S)	6,430	$23.00	$147,890	Direct
Jun 24, 2026	BBNX Beta Bionics, Inc.	Sale(S)	1,406	$15.00	$21,090	Direct
Jun 4, 2026	BBNX Beta Bionics, Inc.	Sale(S)	2,811	$14.00	$39,354	Direct
May 21, 2026	BBNX Beta Bionics, Inc.	Sale(S)	1,998	$9.95	$19,880	Direct
May 21, 2026	BBNX Beta Bionics, Inc.	Award(A)	16,965	-	$0	Direct
Jan 13, 2026	BBNX Beta Bionics, Inc.	Award(A)	3,997	-	$0	Direct
Mar 15, 2025	BBNX Beta Bionics, Inc.	Award(A)	11,247	-	-	Direct
Jan 31, 2025	BBNX Beta Bionics, Inc.	Award(A) Director Stock Option (right to buy)	9,137	-	-	Direct
Jan 31, 2025	BBNX Beta Bionics, Inc.	Award(A) Director Stock Option (right to buy)	9,137	-	-	Direct
Jan 31, 2025	BBNX Beta Bionics, Inc.	Award(A) Director Stock Option (right to buy)	48,730	-	-	Direct

1-10 of 10 transactions

About Jones Christy

Jones Christy (SEC CIK 0002048467) files insider reports with the SEC as Director of Beta Bionics, Inc. (BBNX).

Signal8 holds 8 ownership filings by Jones Christy (1 Form 3, 7 Form 4), filed between Jan 29, 2025 and Sep 23, 2026. Those filings report 10 transactions, from Jan 31, 2025 to Sep 22, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Jones Christy's filings is in IRVINE, CA.

Recent filings by Jones Christy

Sep 22, 2026: Open-market sale of BBNX shares (Form 4, code S).
Jun 24, 2026: Open-market sale of BBNX shares (Form 4, code S).
Jun 4, 2026: Open-market sale of BBNX shares (Form 4, code S).
May 21, 2026: Open-market sale of BBNX shares (Form 4, code S).
May 21, 2026: Grant or award of BBNX shares (Form 4, code A).

Other insiders filing for Beta Bionics, Inc. (BBNX)

Mensinger Mike, Chief Product Officer
Hopman Mark, Chief Commercial Officer
Saint Sean, President & CEO
Russell Steven Jon, Chief Medical Officer
Feider Stephen, Chief Financial Officer
MICHEL GERARD J, Director

How to read Form 4 transaction codes